American Society of Hematology

Fig. 2.

Fig. 2. Median sIL-2R levels for all patients by diagnosis before and after DAB389IL-2 administration. (▿) HD; (•) CTCL; (⧫) NHL.

Median sIL-2R levels for all patients by diagnosis before and after DAB₃₈₉IL-2 administration. (▿) HD; (•) CTCL; (⧫) NHL.

This Feature Is Available To Subscribers Only

Sign In or Create an Account